- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/401 - Proline; Derivatives thereof, e.g. captopril
Patent holdings for IPC class A61K 31/401
Total number of patents in this class: 977
10-year publication summary
|
63
|
72
|
71
|
96
|
73
|
86
|
86
|
82
|
49
|
19
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Azurity Pharmaceuticals, Inc. | 147 |
18 |
| Novartis AG | 11238 |
16 |
| Exela Pharma Sciences, LLC | 18 |
16 |
| Ajinomoto Co., Inc. | 2337 |
13 |
| Boehringer Ingelheim Vetmedica GmbH | 1290 |
11 |
| F. Hoffmann-La Roche AG | 7958 |
10 |
| Convergence Pharmaceuticals Limited | 42 |
10 |
| The Regents of the University of California | 18943 |
9 |
| APR Applied Pharma Research SA | 69 |
9 |
| ADT Pharmaceuticals, LLC | 14 |
9 |
| University of Florida Research Foundation, Inc. | 3883 |
8 |
| ThermoLife International, LLC | 118 |
8 |
| Stealth Biotherapeutics Inc. | 143 |
8 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| Glaxo Group Limited | 4496 |
7 |
| Société des Produits Nestlé S.A. | 9672 |
7 |
| Bristol-myers Squibb Company | 5080 |
7 |
| Takeda Pharmaceutical Company Limited | 2961 |
7 |
| Astellas Pharma Inc. | 1145 |
7 |
| Enanta Pharmaceuticals, Inc. | 420 |
7 |
| Other owners | 782 |